Stock listing

NASDAQ:AVR Anteris Technologies Global Corp. Stock

Home listing (NASDAQ) of Anteris Technologies Global Corp.

Follow Anteris Technologies Global Corp. into a list and get an email when it puts out news.

Share price · NASDAQ:AVR

$4.99 USD -0.22 (-4.2%)

Close on Nov 20, 2026

Past year +47.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.92 – $5.18 USDNov 20, 2026
Volume
1.54M sharesNov 20, 2026
Market cap
$486.5M USDAt the close on Nov 20, 2026 · price × 97.49M shares outstanding
52-week range
$3.30 – $11.06 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7.91M USDMedian day 965,161 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Anteris Technologies Global Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AVR · Home$4.99 USD-0.22 (-4.2%)1,537,886$5.05$5.18$4.92$5.21Close on Nov 20, 2026
ASX:AVR$7.55 AUD-0.33 (-4.2%)6,503$7.81$7.81$7.55$7.88Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AVR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.99-0.22-4.2%$5.05$5.18$4.921,537,886
$5.21-0.11-2.1%$5.28$5.43$5.131,235,045
$5.32-0.38-6.7%$5.63$5.66$5.281,179,226
$5.70+0.28+5.2%$5.48$5.72$5.401,341,441
$5.42-0.44-7.5%$5.81$5.81$5.351,471,123
$5.86-0.34-5.5%$6.15$6.255$5.82965,161
$6.20+0.31+5.3%$6.07$6.23$6.005751,543
$5.89-0.05-0.8%$5.85$6.02$5.77778,730
$5.94+0.25+4.4%$5.76$6.03$5.69669,389
$5.69+0.11+2.0%$5.55$5.79$5.471,213,514
$5.58-0.54-8.8%$6.13$6.20$5.451,851,297
$6.12+0.52+9.3%$5.66$6.13$5.661,156,591
$5.60-0.18-3.1%$5.77$5.875$5.581,170,914
$5.78-0.53-8.4%$6.55$6.562$5.2554,017,767
$6.31-0.11-1.7%$6.33$6.37$6.111,395,367
$6.42+0.32+5.2%$6.05$6.42$6.052,818,538
$6.10+0.10+1.7%$5.96$6.17$5.911,542,723
$6.00+0.22+3.8%$5.78$6.075$5.771,480,448
$5.78-0.09-1.5%$5.85$5.92$5.74739,306
$5.87-0.13-2.2%$6.00$6.08$5.85901,787
$6.00-0.01-0.2%$5.92$6.17$5.8252,096,160
$6.01-0.28-4.5%$6.29$6.47$5.991,392,713
$6.29+0.11+1.8%$6.20$6.525$6.1752,830,358
$6.18+0.13+2.1%$6.09$6.25$6.061,358,818
$6.05-0.31-4.9%$6.34$6.34$6.041,032,900
$6.36+0.10+1.6%$6.23$6.38$6.115825,700
$6.26-0.19-2.9%$6.33$6.468$6.0951,740,000
$6.45-0.20-3.0%$6.61$6.635$6.41764,200
$6.65-0.12-1.8%$6.72$6.763$6.525972,500
$6.77+0.14+2.1%$6.73$6.90$6.641,342,000
$6.63-0.19-2.8%$6.75$6.78$6.5652,470,200
$6.82-0.23-3.3%$6.83$7.08$6.762,454,100
$7.05-0.50-6.6%$7.57$7.655$7.022,641,700
$7.55-0.16-2.1%$7.66$7.745$7.3651,892,800
$7.71+0.10+1.3%$7.97$8.00$7.6551,495,600
$7.61-0.16-2.1%$7.74$7.86$7.521,170,700
$7.77+0.18+2.4%$7.66$7.955$7.54976,400
$7.59-0.15-1.9%$7.80$7.84$7.525782,400
$7.74+0.05+0.7%$7.63$7.755$7.555707,200
$7.69+0.04+0.5%$7.65$7.84$7.49762,700
$7.65+0.03+0.4%$7.60$7.695$7.47779,000
$7.62-0.51-6.3%$8.03$8.035$7.57867,200
$8.13-0.02-0.2%$8.27$8.32$8.055842,900
$8.15-0.01-0.1%$8.20$8.24$7.99741,800
$8.16-0.26-3.1%$8.40$8.57$8.121,809,000
$8.42+0.05+0.6%$8.50$8.60$8.35445,000
$8.37+0.03+0.4%$8.36$8.47$8.26968,200
$8.34-0.38-4.4%$8.68$8.71$8.30583,600
$8.72+0.37+4.4%$8.32$8.73$8.255551,800
$8.35+0.05+0.6%$8.41$8.565$8.10640,300
$8.30-0.23-2.7%$8.35$8.45$8.23842,300
$8.53-0.09-1.0%$8.58$8.74$8.50681,900
$8.62-0.42-4.6%$9.04$9.04$8.61490,500
$9.04+0.32+3.7%$8.665$9.101$8.66362,900
$8.72+0.13+1.5%$8.72$8.755$8.46533,400
$8.59+0.14+1.7%$8.50$8.86$8.493470,400
$8.45-0.16-1.9%$8.48$8.63$8.41568,600
$8.61-0.13-1.5%$8.66$8.745$8.43755,100
$8.74-0.23-2.6%$9.045$9.065$8.69533,500
$8.97+0.02+0.2%$8.95$9.372$8.91469,500
$8.95+0.06+0.7%$8.86$9.045$8.75558,800
$8.89+0.09+1.0%$8.86$8.959$8.718515,200
$8.80-0.18-2.0%$8.89$8.96$8.61802,500
$8.98-0.27-2.9%$9.41$9.41$8.95566,600
$9.25-0.58-5.9%$9.68$9.89$9.0851,171,500
Ticker
NASDAQ:AVR
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Anteris Technologies Global Corp. news

Anteris Technologies Global Corp. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
19 in the last 12 months · 36 in all · newest Nov 22, 2026 · oldest 2024
Decks
28 decks · latest Jan 12, 2026

Where Anteris Technologies Global Corp. is listed

ListingExchangeCountryCurrency
NASDAQ:AVR · Home listing · This pageNASDAQUnited StatesUSD
ASX:AVRASXAustraliaAUD
BOATS:AVRBOATSUnited StatesUSD

Valuation

EV/sales 116× against a median of 4.8×: the highest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$269.6M USD
P/E
Loss
EV/sales
116×
EV/EBITDA
Negative EBITDA
Price/book
2.1×
Gross margin
39.3%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
1.43

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Anteris Technologies Global Corp. · NASDAQ:AVRUS$486.5MUS$269.6Mn/a116×n/a2.1×n/a0.0×1.43
Jin Medical International Ltd. · NASDAQ:ZJYLUS$518.6MUS$509.1M435×24.6×598×17.1×5.8%0.7×0.92
Zhejiang Gongdong Medical Technology Co. Ltd. Class A · SSE:605369US$512.0MUS$407.8M47.7×2.3×n/a2.0×6.0%0.0×n/a
Ion Beam Applications SA · EURONEXT:IBABUS$511.9MUS$594.0M36.6×0.9×12.9×3.9×2.1%1.0×n/a
Contec Medical Systems Co. Ltd. Class A · SZSE:300869US$506.6MUS$348.7Mn/a4.9×n/a2.0×−19.1%0.5×n/a
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class A · SSE:688236US$494.6MUS$175.5M12.1×1.1×3.5×1.1×26.1%0.0×n/a
Avita Medical, Inc. · NASDAQ:RCELUS$490.8MUS$525.8Mn/a6.2×n/an/a−42.6%n/a1.37
Chimin Health Management Co., Ltd. Class A · SSE:603222US$487.9MUS$484.6Mn/a5.0×n/a3.1×−39.2%0.2×n/a
Carlsmed, Inc. · NASDAQ:CARLUS$477.4MUS$432.8Mn/a6.0×n/a6.3×−55.8%0.2×1.34
Nanjing Vishee Medical Technology Co., Ltd. Class A · SSE:688580US$464.0MUS$333.0M19.5×4.8×n/a1.8×34.3%0.0×n/a
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A · SSE:688212US$459.2MUS$417.8Mn/a3.5×n/a2.5×−3.8%0.0×n/a
Median of the othersUS$492.7MUS$425.3M36.6×4.8×12.9×2.5×−0.9%0.2×1.34

Forecasts

4 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
14.00 USD · Analysts' mean
EPS, year to Dec 2026
-1.18 · 5 analysts
Revenue, year to Dec 2026
10.2M · 4 analysts

Team and board

Officers

OfficerRole
Wayne PatersonVice Chairman & CEO
Brent MoenChief Financial Officer
David St DenisPresident & Director
Eric SchwartzChief Legal Officer
Debbie OrmsbyGlobal Investor Relations
Malini ChatterjeeInvestor Relations US
Chris MeduriChief Medical Officer

Board

DirectorRole
David St DenisPresident & Director
Wayne PatersonVice Chairman & CEO

Events

QuarterResultsShare move
Q3 2026Nov 10, 2026 · After close+5.3%
Q2 2026Aug 11, 2026 · After close−3.3%
Q1 2026May 13, 2026+8.2%
Q4 2025Feb 26, 2026 · After close+2.7%
Q3 2025Nov 12, 2025 · After close−2.6%
Q2 2025Aug 11, 2025 · After close+6.0%
Q1 2025May 13, 2025 · After close−9.9%
Q4 2024Feb 26, 2025−1.7%
Q3 2024Nov 27, 2024

Open Events

Decks

DeckKindSlidesDate
JP Morgan 44th Annual Healthcare Conference (January 2026)Conference31 slidesJan 12, 2026
Shareholder Meeting (December 2025)Shareholder meeting59 slidesDec 4, 2025
Shareholder Meeting (December 2025)Shareholder meeting57 slidesDecember 2025
PCR London Valves 2025Conference16 slidesNov 18, 2025
Investor Presentation (October 2025)Investor deck31 slidesOctober 2025
PCR London Valves 2025Conference19 slides2025
IPO Roadshow (December 2024)IPO roadshow34 slidesDec 16, 2024
EuroPCR 2024Conference13 slidesAug 19, 2024
Shareholder Meeting (May 2024)Shareholder meeting80 slidesMay 29, 2024
Shareholder Meeting (May 2024)Shareholder meeting77 slidesMay 29, 2024
All 28 decks
DeckKindSlidesDate
Annual J.P. Morgan Healthcare Conference 2024Conference25 slidesJan 9, 2024
London Valves 2024Conference13 slides2024
TCT 2024Conference13 slides2024
Technical Presentation (November 2023)Technical9 slidesNov 19, 2023
TVT 2023Conference13 slidesOct 13, 2023
Shareholder Meeting (May 2023)Shareholder meeting88 slidesMay 29, 2023
Shareholder Meeting (May 2023)Shareholder meeting86 slidesMay 29, 2023
NWR Virtual Healthcare Conference 2023Conference33 slidesMar 21, 2023
TVT 2023Conference13 slides2023
PCR London Valves 2022Conference13 slidesDec 8, 2022
PCR London Valves 2022Conference10 slidesNov 18, 2022
Shareholder Meeting (May 2022)Shareholder meeting81 slidesMay 25, 2022
Shareholder Meeting (May 2022)Shareholder meeting83 slidesMay 25, 2022
Shareholder Meeting (July 2021)Shareholder meeting38 slidesJul 15, 2021
Shareholder Meeting (July 2021)Shareholder meeting41 slidesJul 15, 2021
Symposium on Next Generation Technologies (July 2020)Conference11 slidesJul 21, 2020
Shareholder Meeting (May 2020)Shareholder meeting34 slidesMay 2020
Admedus — Shareholder Meeting (2019)Shareholder meeting40 slides2019

Open Decks

Financings

RaiseDate
Public offering of common stock
Closed: US$200M raised · US$5.75 a share · Barclays +3
Dealers: Barclays (co-lead), Wells Fargo Securities (co-lead), Cantor (co-lead), Barrenjoey Markets Pty Limited
Use of proceeds: To support the global pivotal PARADIGM trial and advance toward global commercialization of the DurAVR Transcatheter Heart Valve
Jan 22, 2026
Strategic investment of common stock
Closed: US$90M raised · Wells Fargo Securities
Dealers: Wells Fargo Securities (lead)
Buyers: Medtronic plc (up to $90.0 million of shares, 16.0% to 19.99% of shares outstanding after the Offering); Medtronic, plc ($90 million strategic investment)
Use of proceeds: To support the global pivotal PARADIGM trial and advance toward global commercialization of the DurAVR Transcatheter Heart Valve
Jan 22, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$6.00 a share on Dec 12, 2024.

Price
US$6.00 a share
Shares offered
14,800,000 shares of common stock
Offering size
US$88.8 million
Underwriters' option
Up to 2,220,000 more shares
Listing
AVR on the Nasdaq Global Market
Underwriters
TD Cowen, Barclays, Cantor, Lake Street · In the order on the cover
Shares delivered
On or about Dec 16, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 14, 2024
Filed publiclyNov 22, 2024
Amended onceDec 9, 2024
Shares registered with an exchangeDec 10, 2024
Declared effective by the SECDec 12, 2024
Final prospectus, with the priceDec 13, 2024

Open IPO · From the cover of the final prospectus (424B4) filed Dec 13, 2024

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue1.91M2.70M2.73M3.20M5.83M5.46M
Cost of revenue569.0K1.44M1.86M2.90M3.93M2.10M
Gross profit-317.0K1.27M876.8K298.4K1.91M3.36M
Research and development69.1M51.5M31.0M17.6M9.99M3.57M
Selling, general and administrative26.1M28.2M16.0M14.4M8.72M2.18M
Operating income-93.9M-78.4M-48.1M-31.1M-16.9M-13.3M
Depreciation and amortization1.66M1.51M1.16M774.1K640.1K1.01M
EBITDA-92.2M-76.9M-47.0M-30.3M-16.2M-12.3M
Interest expense73.0K47.0K67.1K648.7K1.03M300.6K
Income before tax-94.2M-76.0M-46.8M-30.6M-17.2M-11.8M
Income tax00
Net income-94.1M-76.3M-46.0M-30.6M-17.2M-11.8M
Earnings per share, basic-2.55-3.68-1.28-0.85-0.48-0.33
Earnings per share, diluted-2.55-3.68

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents6.70M70.5M21.1M9.35M15.5M3.36M
Receivables32.0K208.0K1.13M563.7K1.85M652.4K
Inventory152.0K513.0K442.3K355.6K549.8K534.7K
Current assets15.7M74.7M24.2M12.2M18.7M6.24M
Property, plant and equipment5.26M4.77M
Total assets23.0M80.7M30.5M16.0M21.4M9.75M
Accounts payable11.1M5.89M3.14M1.73M2.23M581.9K
Current liabilities21.4M16.6M9.46M6.05M10.2M6.04M
Long-term debt22.0K093.8K
Total debt16.0K3.00K1.69M952.8K4.14M2.92M
Total liabilities23.3M18.0M11.6M6.95M10.9M7.90M
Shareholders' equity-93.0K62.8M19.3M9.03M10.5M1.86M
Shares outstanding41.6M35.9M35.9M35.9M35.9M35.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2015
Cash from operations-77.8M-61.2M-34.6M-29.4M-14.4M-11.1M
Capital spending-1.95M-2.27M-2.39M-1.67M-582.2K-222.5K0
Free cash flow-79.8M-63.5M-37.0M-31.1M-15.0M-11.3M
Cash from investing-596.0K-2.28M-2.58M-992.6K-886.1K5.99M
Cash from financing20.6M112.8M49.3M23.3M27.4M1.46M
Share buybacks-2.74M-998.5K
Change in cash-57.9M49.4M11.7M-6.10M12.1M-2.94M

Open Financials

Filings

FilingDateTypeFiled with
424B3 · ProspectusNov 17, 2026Offer documentSEC
424B3 · ProspectusNov 17, 2026Offer documentSEC
8-K · Current reportNov 10, 2026ResultsSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
ARS · Annual report to shareholdersNov 9, 2026Annual reportSEC
DEF 14A · Proxy statementNov 9, 2026Meeting noticeSEC
10-Q/A · Quarterly report, amendedNov 9, 2026Quarterly reportSEC
10-Q/A · Quarterly report, amendedNov 9, 2026Quarterly reportSEC
10-K/A · Annual report, amendedNov 9, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 5, 2026Big-stake noticeSEC
All 198 filings
FilingDateTypeFiled with
3 · Initial statement of ownershipNov 4, 2026Insider tradeSEC
PRE 14A · Preliminary proxy statementOct 28, 2026Meeting noticeSEC
4 · Change in ownershipOct 8, 2026Insider tradeSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
4 · Change in ownershipOct 1, 2026Insider tradeSEC
424B3 · ProspectusSep 24, 2026Offer documentSEC
8-K · Current reportSep 23, 2026Material contractSEC
424B3 · ProspectusSep 21, 2026Offer documentSEC
8-K · Current reportSep 17, 2026Management or board changeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 16, 2026Insider tradeSEC
424B3 · ProspectusSep 9, 2026Offer documentSEC
8-K · Current reportSep 8, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 3, 2026Big-stake noticeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
424B3 · ProspectusAug 12, 2026Offer documentSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
8-K · Current reportAug 11, 2026ResultsSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
4 · Change in ownershipAug 10, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 7, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 6, 2026Big-stake noticeSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
8-K · Current reportAug 3, 2026Current reportSEC
8-K · Current reportJul 31, 2026Current reportSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
4 · Change in ownershipJul 29, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4 · Change in ownershipJul 28, 2026Insider tradeSEC
S-3ASR · Registration statementJul 1, 2026Offer documentSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
424B3 · ProspectusMay 26, 2026Offer documentSEC
8-K · Current reportMay 22, 2026Material contractSEC
424B5 · ProspectusMay 22, 2026Offer documentSEC
3 · Initial statement of ownershipMay 21, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 19, 2026Insider tradeSEC
424B3 · ProspectusMay 15, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
8-K · Current reportMay 12, 2026Management or board changeSEC
8-K · Current reportMay 12, 2026ResultsSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 4, 2026Big-stake noticeSEC
424B3 · ProspectusApr 30, 2026Offer documentSEC
8-K · Current reportApr 29, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeApr 27, 2026Big-stake noticeSEC
424B3 · ProspectusApr 27, 2026Offer documentSEC
8-K · Current reportApr 23, 2026Material contractSEC
424B3 · ProspectusMar 18, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMar 16, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMar 10, 2026Offer documentSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
8-K · Current reportMar 3, 2026Management or board changeSEC
8-K · Current reportFeb 26, 2026ResultsSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 9, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeJan 29, 2026Big-stake noticeSEC
3 · Initial statement of ownershipJan 29, 2026Insider tradeSEC
424B3 · ProspectusJan 22, 2026Offer documentSEC
8-K · Current reportJan 22, 2026Current reportSEC
8-K · Current reportJan 22, 2026Material contractSEC
424B5 · ProspectusJan 21, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
FWP · Free writing prospectusJan 21, 2026Offer documentSEC
FWP · Free writing prospectusJan 20, 2026Offer documentSEC
424B5 · ProspectusJan 20, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 9, 2026Other filingsSEC
CORRESP · Letter to the SECJan 6, 2026Other filingsSEC
UPLOAD · Letter from the SECJan 6, 2026Other filingsSEC
S-3 · Registration statementJan 2, 2026Offer documentSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
424B3 · ProspectusDec 17, 2025Offer documentSEC
8-K · Current reportDec 15, 2025Management or board changeSEC
EFFECT · Notice that a registration is effectiveDec 12, 2025Other filingsSEC
424B3 · ProspectusDec 11, 2025Offer documentSEC
CORRESP · Letter to the SECDec 9, 2025Other filingsSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
8-K · Current reportDec 4, 2025Meeting outcomeSEC
8-K · Current reportDec 1, 2025Current reportSEC
S-1 · Registration statementNov 26, 2025Offer documentSEC
8-K · Current reportNov 17, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
8-K · Current reportNov 12, 2025ResultsSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
DEF 14A · Proxy statementNov 10, 2025Meeting noticeSEC
ARS · Annual report to shareholdersNov 10, 2025Annual reportSEC
DNov 7, 2025Other filingsSEC
8-K · Current reportNov 3, 2025Current reportSEC
PRE 14A · Preliminary proxy statementOct 30, 2025Meeting noticeSEC
8-K · Current reportOct 27, 2025Current reportSEC
8-K · Current reportOct 27, 2025FinancingSEC
8-K · Current reportOct 24, 2025FinancingSEC
SCHEDULE 13G · Big-stake noticeOct 17, 2025Big-stake noticeSEC
8-K · Current reportOct 15, 2025Current reportSEC
8-K · Current reportOct 15, 2025Current reportSEC
8-K · Current reportSep 29, 2025Meeting outcomeSEC
DEFA14A · Additional proxy materialSep 19, 2025Meeting noticeSEC
8-K · Current reportSep 19, 2025Current reportSEC
DEFA14A · Additional proxy materialSep 11, 2025Meeting noticeSEC
8-K · Current reportSep 11, 2025Current reportSEC
DEFA14A · Additional proxy materialSep 4, 2025Meeting noticeSEC
8-K · Current reportSep 4, 2025Current reportSEC
DEF 14A · Proxy statementAug 18, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
8-K · Current reportAug 11, 2025ResultsSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
PRE 14A · Preliminary proxy statementAug 8, 2025Meeting noticeSEC
8-K · Current reportAug 7, 2025Current reportSEC
8-K · Current reportJul 29, 2025Material contractSEC
3 · Initial statement of ownershipJun 10, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 10, 2025Insider tradeSEC
8-K · Current reportJun 9, 2025Management or board changeSEC
8-K · Current reportMay 13, 2025ResultsSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
10-K/A · Annual report, amendedApr 29, 2025Annual reportSEC
SCHEDULE 13G · Big-stake noticeApr 8, 2025Big-stake noticeSEC
8-K · Current reportMar 31, 2025Current reportSEC
4/A · Change in ownership, amendedMar 21, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 21, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
8-K · Current reportMar 20, 2025Current reportSEC
8-K · Current reportMar 12, 2025ResultsSEC
10-K · Annual reportMar 12, 2025Annual reportSEC
8-K · Current reportMar 6, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 10, 2025Big-stake noticeSEC
3 · Initial statement of ownershipJan 23, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJan 23, 2025Big-stake noticeSEC
8-K · Current reportJan 14, 2025Current reportSEC
8-K · Current reportDec 19, 2024Current reportSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
SEC STAFF LETTERDec 17, 2024Other filingsSEC
3 · Initial statement of ownershipDec 16, 2024Insider tradeSEC
S-8 · Registration statement for employee plansDec 16, 2024Offer documentSEC
8-K · Current reportDec 16, 2024Management or board changeSEC
424B4 · ProspectusDec 13, 2024Offer documentSEC
POS EXDec 13, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveDec 13, 2024Other filingsSEC
3 · Initial statement of ownershipDec 12, 2024Insider tradeSEC
CERT · Exchange's certificate of listingDec 12, 2024Other filingsSEC
3 · Initial statement of ownershipDec 10, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 10, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 10, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 10, 2024Insider tradeSEC
8-A12B · Registration of shares for listing on an exchangeDec 10, 2024Other filingsSEC
CORRESP · Letter to the SECDec 10, 2024Other filingsSEC
CORRESP · Letter to the SECDec 10, 2024Other filingsSEC
S-1/A · Registration statement, amendedDec 9, 2024Offer documentSEC
SEC STAFF LETTERDec 5, 2024Other filingsSEC
S-1 · Registration statementNov 22, 2024Offer documentSEC
CORRESP · Letter to the SECNov 22, 2024Other filingsSEC
UPLOAD · Letter from the SECNov 19, 2024Other filingsSEC
DRSLTR · Letter to the SEC with a draftNov 1, 2024Other filingsSEC
DRS/A · Draft registration statement, amendedNov 1, 2024Offer documentSEC
UPLOAD · Letter from the SECOct 28, 2024Other filingsSEC
DRSLTR · Letter to the SEC with a draftOct 11, 2024Other filingsSEC
DRS/A · Draft registration statement, amendedOct 11, 2024Offer documentSEC
UPLOAD · Letter from the SECAug 26, 2024Other filingsSEC
DRSLTR · Letter to the SEC with a draftAug 9, 2024Other filingsSEC
DRS/A · Draft registration statement, amendedAug 9, 2024Offer documentSEC
UPLOAD · Letter from the SECJun 10, 2024Other filingsSEC
DRS/A · Draft registration statement, amendedMay 13, 2024Offer documentSEC
DRS · Draft registration statementFeb 14, 2024Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Anteris Technologies Global Corp.’s releases · as of Nov 9, 2026

Common shares
97,493,429
Fully diluted
97,493,429

Fully diluted

LineSharesAs of
Common shares97,493,429Nov 9, 2026

Share count over time

CountShares
Nov 9, 202697,493,429

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Fidelity8.48M8.7%US$65.9M+1.62MNov 10, 2026
BlackRock5.45M5.6%US$42.3M−321KNov 13, 2026
Sio Capital Management, LLC5.18M5.3%US$40.2M−367KNov 16, 2026
L1 Capital Pty Ltd4.88M5.0%US$37.9M−2.91MNov 16, 2026
Perceptive Advisors LLC3.43M3.5%US$26.6MNo changeNov 16, 2026
ADAR1 Capital Management, LLC3.24M3.3%US$25.2M+92,225Nov 16, 2026
Bvf Inc3M3.1%US$23.3MNo changeNov 16, 2026
Nantahala Capital Management, LLC2.76M2.8%US$21.4M−4.01MNov 13, 2026
Ra Capital Management, L.P.2.47M2.5%US$19.2M−526KNov 16, 2026
Vanguard2.16M2.2%US$16.8M+237KNov 13, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Geode Capital2.07M2.1%US$16.1M−36,708Nov 6, 2026
Ensign Peak Advisors, Inc2.02M2.1%US$15.7M−370KNov 12, 2026
State Street1.95M2.0%US$15.2M+245KNov 12, 2026
Samlyn Capital, LLC1.93M2.0%US$15MNewNov 16, 2026
Rhenman & Partners Asset Management AB1.54M1.6%US$12MNo changeNov 12, 2026
Citadel1.02M1.0%US$7.9M+406KNov 16, 2026
Affinity Asset Advisors, LLC912K0.94%US$7.09MNo changeNov 13, 2026
Montanova Capital, LLC850K0.87%US$6.6MNo changeNov 16, 2026
Vestal Point Capital, LP850K0.87%US$6.6M−160KNov 16, 2026
Schwab719K0.74%US$5.58M+466KNov 16, 2026
Velan Capital Investment Management LP700K0.72%US$5.44MNo changeNov 16, 2026
Militia Capital Management LLC673K0.69%US$5.23M+3,393Nov 19, 2026
Assenagon Asset Management S.A.645K0.66%US$5.01M−644KOct 15, 2026
Bank of America640K0.66%US$4.97M+446KNov 16, 2026
Walleye Capital LLC611K0.63%US$4.75M+557KNov 13, 2026
Northern Trust601K0.62%US$4.67M−35,218Nov 16, 2026
Goldman Sachs571K0.59%US$4.44M+191KNov 16, 2026
JPMorgan335K0.34%US$2.54M+11,065Nov 12, 2026
Seven Grand Managers, LLC325K0.33%US$2.53M+300KNov 16, 2026
UBS297K0.30%US$2.31M−455KNov 16, 2026
Susquehanna249K0.26%US$1.94M+69,186Nov 16, 2026
BNY219K0.22%US$1.7M−13,409Nov 5, 2026
Federated Hermes, Inc.198K0.20%US$1.54M−144KNov 12, 2026
Nuveen189K0.19%US$1.47M+15,966Nov 10, 2026
Holocene Advisors, LP179K0.18%US$1.39MNo changeNov 16, 2026
Eversept Partners, LP166K0.17%US$1.29MNo changeNov 16, 2026
Jump Financial, LLC156K0.16%US$1.21MNewNov 13, 2026
Morgan Stanley154K0.16%US$1.2M+29,874Nov 13, 2026
Hrt Financial LP141K0.14%US$1.09MNewNov 13, 2026
Barclays139K0.14%US$1.08M+30,946Nov 6, 2026
Qube Research & Technologies Ltd139K0.14%US$1.08MNewNov 13, 2026
Renaissance Technologies124K0.13%US$960K−229KNov 12, 2026
Symmetry Investments LP120K0.12%US$929KNo changeNov 16, 2026
AWM Investment Company, Inc.115K0.12%US$894KNo changeNov 13, 2026
Macquarie Group LTD113K0.12%US$876K+41,864Nov 13, 2026
Bearing Point Capital, LLC105K0.11%US$812K+2,500Nov 13, 2026
XTX Topco Ltd98,6180.10%US$766K+71,723Nov 16, 2026
Marex Group Ltd94,9340.10%US$738KNo changeNov 16, 2026
Rhumbline Advisers93,5020.10%US$727K−4,354Nov 10, 2026
AQR Capital Management LLC93,2440.10%US$725K−3,788Nov 16, 2026

This page holds 50 of 131 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Fidelity Pacific Basin Fund2.16M2.2%US$17.6M−101KJul 31, 2026
iShares Russell 2000 ETF2.14M2.2%US$21.1M+260KJun 30, 2026
Fidelity Series International Small Cap Fund1.99M2.0%US$15.6M+1.62MJul 31, 2026
Fidelity International Small Cap Opportunities Fund1.36M1.4%US$10.7M+915KJul 31, 2026
Fidelity Small Cap Index Fund895K0.92%US$7.01M+109KJul 31, 2026
Vanguard Extended Market Index Fund870K0.89%US$8.57M+12,492Jun 30, 2026
iShares Russell 2000 Value ETF755K0.77%US$7.43MNewJun 30, 2026
Vanguard Russell 2000 Index Fund408K0.42%US$3.52M+240KMay 31, 2026
Fidelity Extended Market Index Fund396K0.41%US$3.42M+22,898May 31, 2026
Fidelity Series Small Cap Core Fund371K0.38%US$2.91MNewJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
iShares Micro-Cap ETF273K0.28%US$2.69M+72,956Jun 30, 2026
JNL Multi-Manager International Small Cap Fund254K0.26%US$2.5MNewJun 30, 2026
Fidelity High Income Fund218K0.22%US$1.71MNo changeJul 31, 2026
Fidelity Small Cap Discovery Fund210K0.21%US$1.64MNewJul 31, 2026
Fidelity SAI High Income Fund199K0.20%US$1.56MNo changeJul 31, 2026
Schwab Small-Cap Index Fund199K0.20%US$1.56M+24,236Jul 31, 2026
Fidelity Series Small Cap Discovery Fund187K0.19%US$1.47MNewJul 31, 2026
Bridge Builder Small/Mid Cap Growth Fund181K0.19%US$1.78M+166KJun 30, 2026
JPMorgan Small Cap Value Fund160K0.16%US$1.57MNewJun 30, 2026
Master Small Cap Index Series153K0.16%US$1.5M+95,745Jun 30, 2026
Fidelity Total Market Index Fund138K0.14%US$1.19M+4,764May 31, 2026
Fidelity Series Total Market Index Fund117K0.12%US$1M+12,662May 31, 2026
Fidelity Small Cap Value Index Fund114K0.12%US$1.13MNewJun 30, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF113K0.12%US$1.11MNewJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF112K0.11%US$1.1MNewJun 30, 2026
Nuveen Small Cap Blend Index Fund108K0.11%US$846K+13,253Jul 31, 2026
Federated Hermes MDT Small Cap Growth Fund98,6070.10%US$773KNewJul 31, 2026
EQ/2000 Managed Volatility Portfolio89,1490.09%US$878K+8,226Jun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund86,4000.09%US$745KNewMay 31, 2026
Vanguard Russell 2000 Growth Index Fund73,9640.08%US$638K+42,386May 31, 2026
Fidelity Series High Income Fund70,4000.07%US$552K+12,500Jul 31, 2026
Fidelity Total International Equity Fund63,2000.06%US$495KNewJul 31, 2026
Nuveen Equity Index Fund62,5380.06%US$490KNewJul 31, 2026
LVIP State Street Small-Cap Index Fund58,4000.06%US$575K+5,800Jun 30, 2026
Fidelity Nasdaq Composite Index Fund58,3910.06%US$503K+36,180May 31, 2026
Schwab Total Stock Market Index Fund53,6270.06%US$420KNo changeJul 31, 2026
EQ/Small Company Index Portfolio48,4000.05%US$477K+46,100Jun 30, 2026
Small Cap Index Fund41,2730.04%US$407K+2,447Jun 30, 2026
Fidelity ZERO Total Market Index Fund40,9640.04%US$321K+1,482Jul 31, 2026
JPMorgan Small Cap Value Portfolio40,1740.04%US$396KNewJun 30, 2026
Global X Russell 2000 ETF39,0430.04%US$306K+4,660Jul 31, 2026
VIP High Income Portfolio36,6000.04%US$361K+7,600Jun 30, 2026
Ultra-Small Company Market Fund35,0000.04%US$345K−25,000Jun 30, 2026
AST PGIM Aggressive Multi-Asset Portfolio33,0000.03%US$325KNewJun 30, 2026
Small Cap Index Fund32,8080.03%US$283K+19,778May 31, 2026
Fidelity Advisor Multi-Asset Income Fund30,1000.03%US$296KNo changeJun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio28,9000.03%US$285K+1,500Jun 30, 2026
Fidelity ZERO Extended Market Index Fund28,0530.03%US$220K+1,454Jul 31, 2026
MetLife Russell 2000 Index Portfolio27,4930.03%US$271K+1,645Jun 30, 2026
EQ/AB Small Cap Growth Portfolio25,7000.03%US$253K+23,400Jun 30, 2026

This page holds 50 of 107 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
L1 Capital Pty Ltd
10% owner
Buy272,695USD 7.18US$1.96MOct 6, 2026
L1 Capital Pty Ltd
10% owner
Buy648,455USD 7.51US$4.87MOct 5, 2026
L1 Capital Pty Ltd
10% owner
Buy236,354USD 7.78US$1.84MOct 2, 2026
L1 Capital Pty Ltd
10% owner
Buy322,940USD 7.60US$2.45MOct 1, 2026
L1 Capital Pty Ltd
10% owner
Buy74,286USD 7.72US$573KSep 30, 2026
L1 Capital Pty Ltd
10% owner
Sale7,800USD 8.83US$68,874Aug 28, 2026
L1 Capital Pty Ltd
10% owner
Sale375,815USD 9.30US$3.5MAug 11, 2026
L1 Capital Pty Ltd
10% owner
Sale251,844USD 9.10US$2.29MAug 10, 2026
L1 Capital Pty Ltd
10% owner
Sale174,721USD 8.10US$1.42MAug 6, 2026
L1 Capital Pty Ltd
10% owner
Sale14,581USD 8.23US$120KAug 5, 2026
All 20 trades
InsiderTradeSharesPriceValueDate
L1 Capital Pty Ltd
10% owner
Sale480,608USD 8.30US$3.99MAug 4, 2026
L1 Capital Pty Ltd
10% owner
Sale475,693USD 8.10US$3.85MAug 3, 2026
L1 Capital Pty Ltd
10% owner
Sale48,711USD 8.15US$397KJul 31, 2026
L1 Capital Pty Ltd
10% owner
Sale558,633USD 8.20US$4.58MJul 30, 2026
L1 Capital Pty Ltd
10% owner
Sale155,505USD 8.04US$1.25MJul 29, 2026
L1 Capital Pty Ltd
10% owner
Sale208,731USD 8.09US$1.69MJul 28, 2026
L1 Capital Pty Ltd
10% owner
Sale232,817USD 8.19US$1.91MJul 27, 2026
L1 Capital Pty Ltd
10% owner
Sale23,000USD 8.13US$187KJul 24, 2026
Knight Susan Elizabeth
Director
Buy11,000USD 9.29US$102KJun 2, 2026
L1 Capital Pty Ltd
10% owner
Buy5,000,000USD 5.75US$28.8MJan 22, 2026

Big stakes

HolderStakeSharesDate
Medtronic plc16.20%15.7MJan 22, 2026
L1 Capital Pty Ltd11.64%11.5MAug 31, 2026
FMR LLC8.70%8.48MSep 30, 2026
Sio Capital Management, LLC5.54%5.38MMar 31, 2026
BlackRock, Inc.5.01%4.88MMar 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Brent Moen
Other companies: Tactile Systems Technology, Inc. (Chief Financial Officer · Sep 2, 2018 – Mar 1, 2023 · Past); Entellus Medical Inc (CFO and Secretary · May 23, 2016 – Feb 28, 2018 · Past); Regis Corporation (SVP, Chief Financial Officer · Feb 3, 2011 – Aug 31, 2012 · Past)
Chief Financial Officer · Since at least Sep 11, 2026
Gregory S. Moss
Other companies: Evommune, Inc. (Chief Business and Legal Officer · Since at least Nov 5, 2025); Kadmon Holdings Inc (EVP, Gen. Coun. / CCO. · Aug 30, 2019 – Nov 9, 2021 · Past); MeiraGTx Holdings plc (Director · Jun 8, 2018 – Jun 8, 2018 · Past)
Director · Since at least Jun 7, 2025
David B. Roberts
Other companies: LeMaitre Vascular, Inc. (President, Board Director · Since at least Oct 18, 2006)
Director · Since at least Jun 7, 2025
John D Seaberg
Other companies: Synovis Life Technologies Inc (Director · Oct 28, 2011 – Oct 28, 2011 · Past)
Director · Since at least Dec 10, 2024
Wayne Paterson
Other companies: Cepheid (Director · Apr 28, 2015 – Nov 4, 2016 · Past)
Vice Chairman & CEO · Since at least Dec 10, 2024
Christopher MeduriChief Medical Officer · Since at least Nov 1, 2026
David St DenisPresident & Director · Since at least Dec 10, 2024
Debbie OrmsbyGlobal Investor Relations · Since at least Oct 27, 2026
Eric SchwartzChief Legal Officer · Since at least Nov 5, 2026
Malini ChatterjeeInvestor Relations US · Since at least Oct 27, 2026
All 14 people
PersonSeat
Matthew McDonnellChief Financial Officer · Since at least Dec 10, 2024
Stephen DenaroDirector · Since at least Dec 10, 2024
Susan Elizabeth KnightDirector · Since at least May 11, 2026
Wenyi GuDirector · Dec 10, 2024 – Dec 16, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Anteris Technologies Global Corp.